Advanced Medical Solutions Group plc (AMS) signed an agreement to buy Peters Surgical SAS for up to €141.4 million (US$154.6 million). The move by AMS for the tissue repair and skin closure manufacturer is part of its strategy to buy assets which will strengthen its product portfolio and broaden its global reach.
Another med-tech acquisition was wiped off the charts after Japan’s Olympus Corp. rescinded the acquisition of South Korean medical device firm Taewoong Medical Co. Ltd. on March 7, after finding “data integrity issues” related to Taewoong’s products.
The Cardiovascular Research Technologies 2024 conference in Washington this week demonstrated continued positive outcomes for patients who underwent transcatheter aortic valve replacement with devices made by Abbott Laboratories, Edwards Lifesciences Corp. or Medtronic plc.
Regulatory harmonization and reliance are the orders of the day at this year’s meeting of the International Medical Device Regulators Forum (IMDRF), but that does not mean individual regulators are waiting for IMDRF to act on their own imperatives.
The U.S. FDA announced March 7 that Cardinal Health of Dublin, Ohio, has expanded a product correction for Monoject devices to a product removal because of manufacturing changes that could affect product performance.
Epitomee Medical Ltd submitted its application to the U.S. FDA for 510k regulatory clearance for its swallowable weight loss capsule. It joins a host of companies offering solutions to the global obesity crisis.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbott, Edwards, Heartflow, Heartsciences, Medtronic, Merakris.
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Affluent Medical, Assure Holdings, Beckman Coulter, Betters Medical, Biocardia, Cara Cara, Clario, Emboline, Fujirebio, GE Healthcare, Hidoc, Mahana, Metabolon, MpowerHealth, Philips, Rhythm AI, Spectral AI, SS Innovations, T2 Biosystems.
RSS
